Gollob Jared bought KYMR
October 13, 2025 · Form 4 insider transaction
Gollob Jared bought 673 shares of Kymera Therapeutics, Inc. at $2.08 per share, a transaction worth $1.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
673
Price
$2.08
Total value
$1.4K
InsiderGollob Jared
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 13, 2025
Filing dateOctober 14, 2025
Shares owned after121,473
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2025 adopted by the reporting person.